While people living with HIV can lead virtually normal lives thanks to antiretroviral therapy (ART), HIV persists in a latent ...

Senate advances Trump-backed $9 billion cuts to foreign aid and public broadcasting, with key GOP defections and changes to secure passage.

Students from the University of Greater Manchester have been celebrating their amazing achievements in the first full week of ...

Attorney General Dave Sunday has announced that Pennsylvania will receive more than $1.28 million as part of a $202 million nationwide settlement with Gilead Sciences, Inc. The agreement resolves ...

PEPFAR has saved more than 25 million lives since its inception. It has strengthened health systems and helped stabilize ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Previous treatment for depression, high BMI and inflammation levels, and early signs of functional impairment may be risk factors for physical function decline in HIV.

The FDA has accepted the New Drug Application for doravirine/islatravir for adults with virologically-suppressed HIV-1 infection.

Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger ...

A separate analysis of the real-world trial found that those who switched from daily antiretroviral treatment to Cabenuva had fewer concerns about treatment.

US funding cuts to global HIV prevention programs are estimated to cause 4 million deaths and 6 million cases of HIV.